Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000496

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Period of report
Jun 19, 2015
Accepted (ET)
Jun 22, 2015 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 19, 2015J1,000,000$0.00D8,773,073D
Common StockF4Jun 19, 2015J64,607$0.00A64,607D
Common StockF4Jun 19, 2015J64,607$0.00D0D
Common StockJun 19, 2015J9,402$0.00A27,330D
Common StockJun 19, 2015J9,403$0.00A27,331D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses